Tilray Brands, Inc. financial data

Symbol
TLRY on Nasdaq
Industry
Medicinal Chemicals & Botanical Products
Location
655 Madison Avenue, 19 Th Floor, New York, NY
Fiscal year end
May 31
Former names
Tilray, Inc. (to 1/10/2022)
Latest financial report
10-Q - Q1 2025 - Apr 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 230 % +31.5%
Quick Ratio 86.5 % +69.5%
Debt-to-equity 24 % -12.6%
Return On Equity -30.7 % -195%
Return On Assets -6.19 % +81.3%
Operating Margin -103 % -210%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.01B shares +30%
Common Stock, Shares, Outstanding 983M shares +27%
Entity Public Float 1.3B USD -45.8%
Common Stock, Value, Issued 99K USD +19.3%
Weighted Average Number of Shares Outstanding, Basic 908M shares +20.4%
Weighted Average Number of Shares Outstanding, Diluted 908M shares +20.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 827M USD +11.2%
Research and Development Expense 644K USD +53%
General and Administrative Expense 173M USD +0.82%
Operating Income (Loss) -855M USD -245%
Nonoperating Income (Expense) -61.7M USD -64.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -952M USD -200%
Income Tax Expense (Benefit) -23.5M USD -64.6%
Net Income (Loss) Attributable to Parent -946M USD -169%
Earnings Per Share, Basic -1.05 USD/shares -110%
Earnings Per Share, Diluted -1.05 USD/shares -110%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 200M USD -12.4%
Marketable Securities, Current 48.5M USD +50.6%
Accounts Receivable, after Allowance for Credit Loss, Current 103M USD +1.64%
Inventory, Net 263M USD +7.89%
Assets, Current 686M USD +1.27%
Other Long-term Investments 10M USD +27.7%
Property, Plant and Equipment, Net 538M USD -7.08%
Operating Lease, Right-of-Use Asset 17M USD -2.63%
Intangible Assets, Net (Excluding Goodwill) 847M USD -8.91%
Goodwill 1.3B USD -35.3%
Other Assets, Noncurrent 5.03M USD -6.73%
Assets 3.4B USD -19.4%
Accounts Payable, Current 98.9M USD +9.71%
Employee-related Liabilities, Current 5.06M USD -66.3%
Accrued Liabilities, Current 88.9M USD +25.6%
Liabilities, Current 262M USD -12.4%
Deferred Income Tax Liabilities, Net 124M USD -5.3%
Operating Lease, Liability, Noncurrent 15.6M USD
Other Liabilities, Noncurrent 1.27M USD +1312%
Liabilities 701M USD -9.95%
Accumulated Other Comprehensive Income (Loss), Net of Tax -52.9M USD -21.7%
Retained Earnings (Accumulated Deficit) -3.57B USD -34.4%
Stockholders' Equity Attributable to Parent 2.73B USD -20.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.7B USD -19.2%
Liabilities and Equity 3.4B USD -19.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -35.3M USD -123%
Net Cash Provided by (Used in) Financing Activities 60.6M USD +332%
Net Cash Provided by (Used in) Investing Activities -49.4M USD -87.9%
Common Stock, Shares Authorized 1.42B shares +18.2%
Common Stock, Shares, Issued 983M shares +27%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -23.2M USD +15.8%
Deferred Tax Assets, Valuation Allowance 790M USD +26.3%
Deferred Tax Assets, Gross 903M USD +26.2%
Operating Lease, Liability 20.7M USD -4.42%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -955M USD -171%
Lessee, Operating Lease, Liability, to be Paid 25.6M USD -7.4%
Property, Plant and Equipment, Gross 656M USD -9.78%
Operating Lease, Liability, Current 5.08M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.79M USD +7.97%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.76M USD +18.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.94M USD -18.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.78M USD +0.17%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 4M USD +17.1%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 114M USD +25.7%
Share-based Payment Arrangement, Expense 25.4M USD -25.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%